Pharmaceutical Quality Control Market Scope
Quality control is an essential operation of the pharmaceutical industry. Drugs must be marketed as safe and therapeutically active formulations whose performance is consistent and predictable. New and better medicinal agents are being produced at an accelerated rate. A significant portion of the CGMP regulations (21 CFR 211) pertains to the quality control laboratory and product testing. Drugs are critical to human health and well-being, so their quality is critical. The primary concern in the pharmaceutical industry is patient safety. The pharmaceutical industry is one of the most heavily regulated industries in the world, And to protect the reputation of the company. Testing raw materials, in-process products, and finished products, only products of the highest quality are released for sale. Growing adoption of digital technology and automation this factor is driving the market and Additional costs involved in quality control and budget constraints in hospitals this factor may restrain the market.
|Unit||Value (USD Million)|
|Key Companies Profiled||Sotera Health Co (United States), BioMerieux SA (France), SGS S.A. (Switzerland), Charles River Laboratories International Inc. (United States), WiXi AppTec (China), Merck KGaA (Germany), Intertek (United Kingdom), APTYS PHARMACEUTICALS (France), Thermo Fisher Scientific Inc. (United States) and Toxikon Corporation (United States)|
Competition among existing players is due to the stiff market share occupied by leading players. The industry leader is engaged in offering innovative and superior-quality products to cater to the ever-growing demand for automation in the industry. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Pharmaceutical Quality Control market throughout the predicted period.
Sotera Health Co (United States), BioMerieux SA (France), SGS S.A. (Switzerland), Charles River Laboratories International Inc. (United States), WiXi AppTec (China), Merck KGaA (Germany), Intertek (United Kingdom), APTYS PHARMACEUTICALS (France), Thermo Fisher Scientific Inc. (United States) and Toxikon Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Novovitae (United States), Sartorius AG (Germany), REMI Group (India), Perkin Elmer (United States), National Quality Control laboratory (Kenya), Lucideon Limited (United States), ALTEN Group (France), Zahrawi Group (Dubai) and InphA (Italy).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
The study have segmented the market of Global Pharmaceutical Quality Control market by Type and Region with country level break-up.
On the basis of geography, the market of Pharmaceutical Quality Control has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.
Market Leaders and their expansionary development strategiesSGS Announces the Acquisition of Quay Pharmaceuticals Limited. Quay Pharmaceuticals Limited (Quay Pharma), is a UK-based provider of innovative, formulation research and development services for the global biopharmaceutical sector.
In December 2022, Labcorp, a leading global life sciences company, announced that they larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.
Influencing Trend:Increase safety, awareness, and Precaution after the covid-19 pandemic
Market Growth Drivers:Growing adoption of digital technology and automation
Challenges:Lack of effective quality management system
Restraints:Additional costs involved in quality control and budget constraints in hospitals
Opportunities:Technological advancements in pharma quality control laboratory
Key Target AudiencePharma Manufacturers, suppliers, Governments regulatory, Industry Experts, End Users and Others